Search Results
Found 1 results
510(k) Data Aggregation
K Number
K041177Device Name
SYNTHACER; SYNTRICER
Manufacturer
Date Cleared
2005-06-23
(414 days)
Product Code
Regulation Number
888.3045Why did this record match?
Applicant Name (Manufacturer) :
MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AG
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
Synthacer® Calcium Salt Bone Void Filler is intended only for use as a bone void filler for voids or gaps in bone that are not intrinsic to the stability of the bony structure. Synthacer® is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury.
Syntricer® Calcium Salt Bone Void Filler is intended only for use as a bone void filler for voids or gaps in bone that are not intrinsic to the stability of the bony structure. Syntricer® is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury.
Device Description
Synthacer® Calcium Salt Bone Void Filler is a porous calcium phosphate bone void filler for the repair of bony defects. It is an osteoconductive porous implant with a trabecular structure that resembles the multidirectional interconnected porosity of human cancellous bone. Pore diameter averages 600um and the average porosity is 60 - 80%. The implant is provided sterile in block. cylinder, morsel and ball form. Synthacer® is composed of a calcium phosphate ceramic which is at least 95% pure hydroxyapatite Cas(PO4)3OH.
Synthacer® promotes three-dimensional regeneration of bone in the defect site into which it is implanted. When Synthacer® is placed in direct contact with viable host bone, new bone growth occurs in apposition to the calcium phosphate surfaces of the implant. As the Synthacer® is resorbed, bone grows into the space previously occupied by the scaffold the implant provides. Synthacer® is radiopaque.
Syntricer® Calcium Salt Bone Void Filler is intended only for use as a bone void filler for yoids or gaps in bone that are not intrinsic to the stability of the bony structure. Syntricer® is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury. Syntricer® should not be used to treat large defects that in the surgeon's opinion would not heal spontaneously. Pore diameter averages 600um and the average porosity is 60 -80%. Syntricer® is composed of a calcium phosphate ceramic which is at least 95% pure tricalcium phosphate Ca3(PO4)2. The implant is provided sterile in block, cylinder, morsel and ball form.
Syntricer® is intended to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). Following placement in the bony void, the Syntricer® will slowly resorb and be replaced with bone over time during the healing process.
Ask a Question
Ask a specific question about this device
Page 1 of 1